MX9709462A - Acrilonitrilos diheterociclicos como inhibidores de la proliferacion de celulas del musculo liso. - Google Patents

Acrilonitrilos diheterociclicos como inhibidores de la proliferacion de celulas del musculo liso.

Info

Publication number
MX9709462A
MX9709462A MX9709462A MX9709462A MX9709462A MX 9709462 A MX9709462 A MX 9709462A MX 9709462 A MX9709462 A MX 9709462A MX 9709462 A MX9709462 A MX 9709462A MX 9709462 A MX9709462 A MX 9709462A
Authority
MX
Mexico
Prior art keywords
cell proliferation
smooth muscle
muscle cell
diheterocyclic
acrylonitriles
Prior art date
Application number
MX9709462A
Other languages
English (en)
Other versions
MXPA97009462A (es
Inventor
Hassan Mahmoud Elokdah
Sie-Yearl Chai
Theodore Sylvester Sulkowski
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MXPA97009462A publication Critical patent/MXPA97009462A/es
Publication of MX9709462A publication Critical patent/MX9709462A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describe en la presente compuestos de la formula (I) donde Ar1 y Ar2 son, independientemente, piridinilo, quinolinilo, dihidro-1,4-benzodioxinilo, pirrolilo, azaindolilo o carbazolilo o una sal farmacéuticamente aceptable de los mismos, los cuales son utiles como inhibidores de la proliferacion de células del musculo liso.
MX9709462A 1995-06-06 1996-06-03 Acrilonitrilos diheterociclicos como inhibidores de la proliferacion de celulas del musculo liso. MX9709462A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08470603 1995-06-06
US08/470,603 US5710164A (en) 1995-06-06 1995-06-06 Diheterocyclic styryl nitriles
PCT/US1996/008376 WO1996039387A1 (en) 1995-06-06 1996-06-03 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors

Publications (2)

Publication Number Publication Date
MXPA97009462A MXPA97009462A (es) 1998-02-01
MX9709462A true MX9709462A (es) 1998-02-28

Family

ID=23868264

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9709462A MX9709462A (es) 1995-06-06 1996-06-03 Acrilonitrilos diheterociclicos como inhibidores de la proliferacion de celulas del musculo liso.

Country Status (19)

Country Link
US (1) US5710164A (es)
EP (1) EP0835244B1 (es)
JP (1) JPH11506754A (es)
KR (1) KR19990022523A (es)
CN (1) CN1192202A (es)
AR (1) AR002750A1 (es)
AT (1) ATE210120T1 (es)
AU (1) AU711619B2 (es)
BR (1) BR9608976A (es)
CA (1) CA2223388A1 (es)
DE (1) DE69617686T2 (es)
ES (1) ES2166447T3 (es)
HU (1) HUP9900660A3 (es)
IL (1) IL118386A0 (es)
MX (1) MX9709462A (es)
NZ (1) NZ309995A (es)
PT (1) PT835244E (es)
WO (1) WO1996039387A1 (es)
ZA (1) ZA964620B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4496586B2 (ja) * 2000-01-24 2010-07-07 日産化学工業株式会社 キノリルアクリロニトリルの製造法及びその中間体
US8124625B2 (en) 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
UA105162C2 (uk) * 2005-03-30 2014-04-25 Кабусики Кайся Якулт Хонса Похідне акрилонітрилу та його застосування як інгібітору bcrp/abcg2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2080581A1 (en) * 1990-04-16 1991-10-17 Alfred P. Spada Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase
IL97873A0 (en) * 1990-04-16 1992-06-21 Yissum Res Dev Co Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
US5302606A (en) * 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase

Also Published As

Publication number Publication date
DE69617686T2 (de) 2002-08-08
HUP9900660A3 (en) 2001-09-28
ATE210120T1 (de) 2001-12-15
KR19990022523A (ko) 1999-03-25
PT835244E (pt) 2002-04-29
US5710164A (en) 1998-01-20
AU6030496A (en) 1996-12-24
AU711619B2 (en) 1999-10-21
EP0835244B1 (en) 2001-12-05
IL118386A0 (en) 1996-09-12
AR002750A1 (es) 1998-04-29
DE69617686D1 (de) 2002-01-17
ZA964620B (en) 1997-12-04
EP0835244A1 (en) 1998-04-15
NZ309995A (en) 2000-07-28
HUP9900660A2 (hu) 2000-03-28
CA2223388A1 (en) 1996-12-12
JPH11506754A (ja) 1999-06-15
CN1192202A (zh) 1998-09-02
WO1996039387A1 (en) 1996-12-12
ES2166447T3 (es) 2002-04-16
BR9608976A (pt) 1999-06-29

Similar Documents

Publication Publication Date Title
MD1616F2 (en) Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
ZA9610315B (en) Naphthyl-substituted benzimidazole derivates as anti-coagulants
MD1632F2 (en) Bicyclic compounds, method of inhibiting the tyrosine kinases receptors as epidermal growth factor, pharmaceutical composition, methods of preventing blastocyte implantation and treatment of mammals
GB0004297D0 (en) 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
MY138239A (en) Nitrogen containing heterobicycles as factor xa inhibitors
IL130260A (en) 3-thiocarbamoylpyrazole derivatives as pesticides
EP1126849A4 (en) HETEROCYCLIC POTASSIAL CHANNEL INHIBITORS
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
CY2538B1 (en) Tetrahydropyrido compounds
KR20000005379A (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
PL330908A1 (en) Inhibitors of prenyl transferases
GR1002883B (el) Νεα παραγωγα της 2, 3-βενζοδιαζεπινης
PL367774A1 (en) Synthesis and intermediates
JO2065B1 (en) Tri-azin compounds
IN187760B (es)
MX9709462A (es) Acrilonitrilos diheterociclicos como inhibidores de la proliferacion de celulas del musculo liso.
BG105249A (en) Fkbp inhibitors
EP0949926A4 (en) BENZODIAZEPINE HYDROCIDE DERIVATIVES AS HIV INTERASE INHIBITORS
MX9900914A (es)
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija
EP1202628A4 (en) HYPOXANTHIN AND THIOHYPXANTHIN COMPOUNDS
HK1036978A1 (en) Enantioselective synthesis
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
WO2000031100A3 (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation